Unity Biotechnology, Inc.UBXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank88
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.63
↑ 70% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-2.12
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -0.63 | +11.6% |
| 2023 | -0.72 | -22.3% |
| 2022 | -0.59 | +56.4% |
| 2021 | -1.34 | +52.8% |
| 2020 | -2.84 | +25.8% |
| 2019 | -3.83 | +36.4% |
| 2018 | -6.02 | -369.5% |
| 2017 | -1.28 | +31.9% |
| 2016 | -1.88 | - |